Apogee Therapeutics Ownership | Who Owns Apogee Therapeutics?
Apogee Therapeutics Ownership Summary
Apogee Therapeutics is owned by 104.85% institutional investors, 11.64% insiders. Parallel advisors is the largest institutional shareholder, holding 0% of APGE shares.
APGE Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Apogee Therapeutics | 104.85% | 11.64% | -16.49% |
Sector | Healthcare Stocks | 57.39% | 9.93% | 32.68% |
Industry | Biotech Stocks | 68.48% | 9.65% | 21.87% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Parallel advisors | - | - | - |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Parallel advisors | - | - | - |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Parallel advisors | - | - | -6.00 |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Parallel advisors | - | - | -6.00 |
Sold Out
Holder | Change |
---|---|
Parallel advisors | -6.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Dec 31, 2024 | 162 | 10.96% | 57,868,275 | 3.16% | 104 | 1.07% | 97 | 29.33% | 38 | -17.39% |
Sep 30, 2024 | 146 | 4.29% | 56,094,430 | 3.58% | 98 | 1.08% | 75 | -7.41% | 46 | 12.20% |
Jun 30, 2024 | 140 | - | 54,153,585 | 2.36% | 95 | 0.86% | 81 | -28.32% | 41 | 115.79% |
Mar 31, 2024 | 140 | 64.71% | 52,903,025 | 26.66% | 105 | 1.55% | 113 | 109.26% | 19 | 111.11% |
Dec 31, 2023 | 85 | 16.44% | 41,768,396 | 4.13% | 82 | 1.32% | 54 | -26.03% | 9 | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Apr 02, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | $87.87K |
Apr 02, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | $33.42K |
Apr 02, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | $18.52K |
Mar 05, 2025 | Dambkowski Carl | Chief Medical Officer | Sell | $48.46K |
Mar 05, 2025 | HENDERSON MICHAEL THOMAS | Chief Executive Officer | Sell | $219.63K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q1 | - | 10 |
2024 Q4 | 2 | 13 |
2024 Q3 | - | 11 |
2024 Q1 | - | - |
2023 Q4 | - | - |
APGE Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools